Literature DB >> 27057431

Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis.

Gautier Stoll1, Laurence Zitvogel2, Guido Kroemer3.   

Abstract

Recently, we interrogated public microarray databases with regard to the expression patterns of metagenes corresponding to major immune cell subtypes present in malignant tumors. This analysis, which involved approximately 3,500 tumor samples, revealed organ-specific differences in the composition of the immune infiltrate as well as in the correlation among distinct cell-type specific metagenes, reflecting changes in the functional organization of the anticancer immune response.

Entities:  

Keywords:  Breast cancer; colorectal carcinoma; melanoma non-small cell lung cancer; meta-analysis of microarrays

Year:  2015        PMID： 27057431      PMCID： PMC4801430          DOI： 10.1080/2162402X.2015.1067746

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Authors:  Antonella Sistigu; Takahiro Yamazaki; Erika Vacchelli; Kariman Chaba; David P Enot; Julien Adam; Ilio Vitale; Aicha Goubar; Elisa E Baracco; Catarina Remédios; Laetitia Fend; Dalil Hannani; Laetitia Aymeric; Yuting Ma; Mireia Niso-Santano; Oliver Kepp; Joachim L Schultze; Thomas Tüting; Filippo Belardelli; Laura Bracci; Valentina La Sorsa; Giovanna Ziccheddu; Paola Sestili; Francesca Urbani; Mauro Delorenzi; Magali Lacroix-Triki; Virginie Quidville; Rosa Conforti; Jean-Philippe Spano; Lajos Pusztai; Vichnou Poirier-Colame; Suzette Delaloge; Frederique Penault-Llorca; Sylvain Ladoire; Laurent Arnould; Joanna Cyrta; Marie-Charlotte Dessoliers; Alexander Eggermont; Marco E Bianchi; Mikael Pittet; Camilla Engblom; Christina Pfirschke; Xavier Préville; Gilles Uzè; Robert D Schreiber; Melvyn T Chow; Mark J Smyth; Enrico Proietti; Fabrice André; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2014-10-26       Impact factor: 53.440

2.  An immunosurveillance mechanism controls cancer cell ploidy.

Authors:  Laura Senovilla; Ilio Vitale; Isabelle Martins; Maximilien Tailler; Claire Pailleret; Mickaël Michaud; Lorenzo Galluzzi; Sandy Adjemian; Oliver Kepp; Mireia Niso-Santano; Shensi Shen; Guillermo Mariño; Alfredo Criollo; Alice Boilève; Bastien Job; Sylvain Ladoire; François Ghiringhelli; Antonella Sistigu; Takahiro Yamazaki; Santiago Rello-Varona; Clara Locher; Vichnou Poirier-Colame; Monique Talbot; Alexander Valent; Francesco Berardinelli; Antonio Antoccia; Fabiola Ciccosanti; Gian Maria Fimia; Mauro Piacentini; Antonio Fueyo; Nicole L Messina; Ming Li; Christopher J Chan; Verena Sigl; Guillaume Pourcher; Christoph Ruckenstuhl; Didac Carmona-Gutierrez; Vladimir Lazar; Josef M Penninger; Frank Madeo; Carlos López-Otín; Mark J Smyth; Laurence Zitvogel; Maria Castedo; Guido Kroemer
Journal:  Science       Date:  2012-09-28       Impact factor: 47.728

Review 3.  The immune contexture in human tumours: impact on clinical outcome.

Authors:  Wolf Herman Fridman; Franck Pagès; Catherine Sautès-Fridman; Jérôme Galon
Journal:  Nat Rev Cancer       Date:  2012-03-15       Impact factor: 60.716

Review 4.  Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance.

Authors:  Laurence Zitvogel; Lorenzo Galluzzi; Mark J Smyth; Guido Kroemer
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 5.  New insights into cancer immunoediting and its three component phases--elimination, equilibrium and escape.

Authors:  Deepak Mittal; Matthew M Gubin; Robert D Schreiber; Mark J Smyth
Journal:  Curr Opin Immunol       Date:  2014-02-14       Impact factor: 7.486

6.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

Authors:  Gabriela Bindea; Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Maximilian Waldner; Anna C Obenauf; Helen Angell; Tessa Fredriksen; Lucie Lafontaine; Anne Berger; Patrick Bruneval; Wolf Herman Fridman; Christoph Becker; Franck Pagès; Michael R Speicher; Zlatko Trajanoski; Jérôme Galon
Journal:  Immunity       Date:  2013-10-17       Impact factor: 31.745

7.  Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies.

Authors:  Gautier Stoll; Gabriela Bindea; Bernhard Mlecnik; Jérôme Galon; Laurence Zitvogel; Guido Kroemer
Journal:  Oncotarget       Date:  2015-05-20

8.  Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.

Authors:  Gautier Stoll; David Enot; Bernhard Mlecnik; Jérôme Galon; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2014-02-27       Impact factor: 8.110

9.  An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy.

Authors:  Mickaël Michaud; Xiaoqi Xie; José Manuel Bravo-San Pedro; Laurence Zitvogel; Eileen White; Guido Kroemer
Journal:  Oncoimmunology       Date:  2014-07-03       Impact factor: 8.110

Review 10.  Trial Watch: Chemotherapy with immunogenic cell death inducers.

Authors:  Erika Vacchelli; Fernando Aranda; Alexander Eggermont; Jérôme Galon; Catherine Sautès-Fridman; Isabelle Cremer; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2014-03-01       Impact factor: 8.110
  10 in total
  9 in total

1.  Metabolic enzymes expressed by cancer cells impact the immune infiltrate.

Authors:  Gautier Stoll; Margerie Kremer; Normal Bloy; Adrien Joseph; Maria Castedo; Guillaume Meurice; Christophe Klein; Lorenzo Galluzzi; Judith Michels; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-03-30       Impact factor: 8.110

2.  Pro-necrotic molecules impact local immunosurveillance in human breast cancer.

Authors:  Gautier Stoll; Yuting Ma; Heng Yang; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2017-04-17       Impact factor: 8.110

3.  Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate.

Authors:  Sylvain Ladoire; Laura Senovilla; David Enot; François Ghiringhelli; Vichnou Poirier-Colame; Kariman Chaba; Gulsun Erdag; Jochen T Schaefer; Donna H Deacon; Laurence Zitvogel; Craig L Slingluff; Guido Kroemer
Journal:  Oncoimmunology       Date:  2016-03-16       Impact factor: 8.110

Review 4.  Emerging biomarkers for the combination of radiotherapy and immune checkpoint blockers.

Authors:  Claire Lhuillier; Claire Vanpouille-Box; Lorenzo Galluzzi; Silvia Chiara Formenti; Sandra Demaria
Journal:  Semin Cancer Biol       Date:  2017-12-16       Impact factor: 15.707

5.  The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer.

Authors:  Sylvain Ladoire; David Enot; Laura Senovilla; François Ghiringhelli; Vichnou Poirier-Colame; Kariman Chaba; Michaela Semeraro; Marie Chaix; Frédérique Penault-Llorca; Laurent Arnould; Marie Laure Poillot; Patrick Arveux; Suzette Delaloge; Fabrice Andre; Laurence Zitvogel; Guido Kroemer
Journal:  Autophagy       Date:  2016-03-16       Impact factor: 16.016

6.  Contribution of annexin A1 to anticancer immunosurveillance.

Authors:  Elisa Elena Baracco; Gautier Stoll; Peter Van Endert; Laurence Zitvogel; Erika Vacchelli; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-08-14       Impact factor: 8.110

7.  Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours.

Authors:  Pedro Marques; Sayka Barry; Eivind Carlsen; David Collier; Amy Ronaldson; Sherine Awad; Neil Dorward; Joan Grieve; Nigel Mendoza; Samiul Muquit; Ashley B Grossman; Frances Balkwill; Márta Korbonits
Journal:  Acta Neuropathol Commun       Date:  2019-11-08       Impact factor: 7.801

8.  Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.

Authors:  Mariel Garcia-Chagollan; Irma Edith Carranza-Torres; Pilar Carranza-Rosales; Nancy Elena Guzmán-Delgado; Humberto Ramírez-Montoya; María Guadalupe Martínez-Silva; Ignacio Mariscal-Ramirez; Carlos Alfredo Barrón-Gallardo; Ana Laura Pereira-Suárez; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

9.  Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts.

Authors:  Gautier Stoll; Jonathan Pol; Vassili Soumelis; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2018-08-06       Impact factor: 8.110
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.